SCIEN & EE 292E: Mobile VR for vision testing and treatment

Topic: 
Mobile VR for vision testing and treatment
Wednesday, June 6, 2018 - 4:30pm
Venue: 
Packard 101
Speaker: 
Dr. Ben Backus (CTO of Vivid Vision)
Abstract / Description: 

Consumer-level HMDs are adequate for many medical applications. Vivid Vision (VV) takes advantage of their low cost, light weight, and large VR gaming code base to make vision tests and treatments. The company's software is built using the Unity engine, which allows for multiplatform support.in the Unity framework, allowing it to run on many hardware platforms. New headsets are available every six months or less, which creates interesting challenges within in the medical device space. VV's flagship product is the commercially available Vivid Vision System, used by more than 120 clinics to test and treat binocular dysfunctions such as convergence difficulties, amblyopia, strabismus, and stereo blindness. VV has recently developed a new, VR-based visual field analyzer.

Bio:

Ben Backus was Empire Innovation Associate Professor in Manhattan at the Graduate Center of the SUNY College of Optometry until October 2017, when he gave up tenure and moved to San Francisco to be Chief Science Officer at Vivid Vision, Inc. He still teaches and leads NIH-funded research in New York. He has training in mathematics (BA, Swarthmore), human vision (PhD, UC Berkeley), and visual neuroscience (postdoc, Stanford). He was a math teacher in the Oakland Public Schools and a professor of Psychology at the University of Pennsylvania. He makes a good Meyer limoncello.